Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
AnteoTech Ltd ( (AU:ADO) ) has shared an update.
AnteoTech Ltd, an ASX-listed supplier of advanced materials to the battery and life sciences diagnostics sectors, builds on a proprietary cross-linking chemistry platform to deliver products that enhance battery performance and point-of-care test sensitivity and reliability. Its portfolio spans silicon anode additives and ceramic separator solutions for batteries, as well as activation chemistries for vaccines and diagnostic manufacturers.
The company announced it will present at the NWR Communications Virtual Healthcare Conference, with Managing Director and CEO Merrill Gray scheduled to speak on 26 March 2026. The online presentation and subsequent recording, to be hosted via webinar and shared on AnteoTech’s digital channels, offers investors and stakeholders an additional forum to engage with management and gain insight into the company’s strategy and developments in its healthcare-related activities.
The most recent analyst rating on (AU:ADO) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on AnteoTech Ltd stock, see the AU:ADO Stock Forecast page.
More about AnteoTech Ltd
AnteoTech Ltd, listed on the ASX under ticker ADO, supplies advanced material solutions to the global battery materials and life sciences diagnostics markets. The company leverages its proprietary cross-linking chemistry platform to develop products such as Anteo X performance additives, Ultranode high-silicon anode formulations, Anteo S for ceramic separators and the AnteoBind suite, targeting high-performance, low-cost and sustainable materials and more sensitive, reliable diagnostic tests.
Average Trading Volume: 3,459,224
Technical Sentiment Signal: Sell
Current Market Cap: A$32.7M
Find detailed analytics on ADO stock on TipRanks’ Stock Analysis page.